Search research articles
Contact Us
Filters
Showing results (221-230 of 259) with videos related to
Page
of 26
Sort By:
Biochemical and Biophysical Research Communications
|
February 28, 1994
Expression of the p53 tumour suppressor gene product is a determinant of chemosensitivity
R D Petty, I A Cree, L A Sutherland, et al.
Histopathology
|
October 31, 2002
The assessment of proliferating cell nuclear antigen (PCNA)immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis
A L Woods, P A Hall, N A Shepherd, et al.
Digestion
|
January 1, 1991
Proliferating cell nuclear antigen immunolocalization in gastro-intestinal epithelia
C E Sarraf, C S McCormick, G R Brown, et al.
Histopathology
|
July 1, 1991
The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis
A L Woods, P A Hall, N A Shepherd, et al.
Carcinogenesis
|
August 30, 2000
Defective nuclear localization of p53 protein in a Chinese hamster cell line is associated with the formation of stable cytoplasmic protein multimers in cells with gene amplification
L Ottaggio, S Bozzo, F Moro, et al.
Oncogene
|
November 21, 1996
Identification of novel mdm2 binding peptides by phage display
V Böttger, A Böttger, S F Howard, et al.
Oncogene
|
February 2, 1999
Comparative study of the p53-mdm2 and p53-MDMX interfaces
V Böttger, A Böttger, C Garcia-Echeverria, et al.
The Journal of Biological Chemistry
|
August 1, 1997
HSP70 binding sites in the tumor suppressor protein p53
A M Fourie, T R Hupp, D P Lane, et al.
Lancet (London, England)
|
March 7, 1992
Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners
K H Vähäkangas, J M Samet, R A Metcalf, et al.
Histopathology
|
July 1, 1991
Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA)
C C Yu, P A Hall, C D Fletcher, et al.
Page
of 26
Search research articles
Search
Showing results (221-230 of 259) with videos related to
Sort By:
Page
of 26
Biochemical and Biophysical Research Communications
|
February 28, 1994
Expression of the p53 tumour suppressor gene product is a determinant of chemosensitivity
R D Petty, I A Cree, L A Sutherland, et al.
Histopathology
|
October 31, 2002
The assessment of proliferating cell nuclear antigen (PCNA)immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S + G2 + M phase fraction (flow cytometric analysis) and prognosis
A L Woods, P A Hall, N A Shepherd, et al.
Digestion
|
January 1, 1991
Proliferating cell nuclear antigen immunolocalization in gastro-intestinal epithelia
C E Sarraf, C S McCormick, G R Brown, et al.
Histopathology
|
July 1, 1991
The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis
A L Woods, P A Hall, N A Shepherd, et al.
Carcinogenesis
|
August 30, 2000
Defective nuclear localization of p53 protein in a Chinese hamster cell line is associated with the formation of stable cytoplasmic protein multimers in cells with gene amplification
L Ottaggio, S Bozzo, F Moro, et al.
Oncogene
|
November 21, 1996
Identification of novel mdm2 binding peptides by phage display
V Böttger, A Böttger, S F Howard, et al.
Oncogene
|
February 2, 1999
Comparative study of the p53-mdm2 and p53-MDMX interfaces
V Böttger, A Böttger, C Garcia-Echeverria, et al.
The Journal of Biological Chemistry
|
August 1, 1997
HSP70 binding sites in the tumor suppressor protein p53
A M Fourie, T R Hupp, D P Lane, et al.
Lancet (London, England)
|
March 7, 1992
Mutations of p53 and ras genes in radon-associated lung cancer from uranium miners
K H Vähäkangas, J M Samet, R A Metcalf, et al.
Histopathology
|
July 1, 1991
Haemangiopericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA)
C C Yu, P A Hall, C D Fletcher, et al.
Page
of 26